Well Referenced

Tag: O2-O3-AHT

Oxygen-ozone therapy as support and palliative therapy in 50 cancer patients with fatigue – A short report

This 2018 short report by Tirelli et al. evaluated the use of oxygen-ozone autohemotherapy (O2-O3-AHT) as a supportive treatment for cancer-related fatigue. Fifty patients with various cancers (breast, lung, colon, renal, prostate, melanoma, hepatocellular carcinoma) received O2-O3-AHT twice weekly for one month, followed by twice-monthly maintenance therapy. Fatigue severity was

Read More »
June 26, 2025 No Comments

Sjögren syndrome successfully treated with oxygen-ozone auto-hemotherapy (O2-O3-AHT): a case report

This 2022 case report details the treatment of a 69-year-old female patient with primary Sjögren syndrome (SS) using oxygen-ozone autohemotherapy (O2-O3-AHT). The patient, presenting with ocular dryness, fatigue, and pain, underwent two cycles of three O2-O3-AHT sessions between December 2020 and January 2021. Post-treatment, she experienced rapid symptom relief without

Read More »
June 26, 2025 No Comments

Fibromyalgia treated with oxygen-ozone auto-haemotherapy (O2-O3-AHT): a case study on 200 patients with a modified 10-PI-NRS evaluation

This study evaluated the efficacy of oxygen-ozone autohemotherapy (O2-O3-AHT) for treating fibromyalgia (FM), a chronic condition characterized by pain, fatigue, and musculoskeletal issues. Involving 200 patients, the study demonstrated that 76% of participants experienced significant rehabilitation of musculoskeletal function and reduced arthralgia after 3-4 O2-O3-AHT sessions. Pain scores measured using

Read More »
June 26, 2025 No Comments